Guoli Feng

Zunyi, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Reflections on prevention and treatment of post-thyroidectomy hypoparathyroidism: current management approaches and future prospects.

Reflections on prevention and treatment of post-thyroidectomy hypoparathyroidism: current management approaches and future prospects.

Journal: Frontiers in endocrinology

Published: December 15, 2025

SLC26A9 in triple-negative breast cancer stem cells: a network pharmacology and molecular modeling study.

SLC26A9 in triple-negative breast cancer stem cells: a network pharmacology and molecular modeling study.

Journal: Frontiers in bioengineering and biotechnology

Published: September 11, 2025

WTAP-mediated m6A modification of PRMT1 regulates cuproptosis to promote anaplastic thyroid carcinoma progression.

WTAP-mediated m6A modification of PRMT1 regulates cuproptosis to promote anaplastic thyroid carcinoma progression.

Journal: Tissue & cell

Published: August 11, 2025

Peri-Lymph Node Tattooing with Carbon Nanoparticles Suspension: A Novel Strategy for Targeted Axillary Dissection in Breast Cancer.

Peri-Lymph Node Tattooing with Carbon Nanoparticles Suspension: A Novel Strategy for Targeted Axillary Dissection in Breast Cancer.

Journal: International journal of nanomedicine

Published: May 16, 2025

PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma.

PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma.

Journal: Oncology reports

Published: March 20, 2023

Oncotype DX 21-gene test has a low recurrence score in both pure and mixed mucinous breast carcinoma.

Oncotype DX 21-gene test has a low recurrence score in both pure and mixed mucinous breast carcinoma.

Journal: Oncology letters

Published: May 26, 2021

Sorafenib and radioiodine-refractory differentiated thyroid cancer (RR-DTC): a systematic review and meta-analysis.

Sorafenib and radioiodine-refractory differentiated thyroid cancer (RR-DTC): a systematic review and meta-analysis.

Journal: Endocrine

Published: July 11, 2019

Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer.

Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer.

Journal: Cancer cell international

Published: August 02, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026